Key Highlights
- NBIS shares climbed approximately 8.95% during Wednesday’s session, reaching a 52-week peak of $179.96
- The company announced plans to purchase Eigen AI for roughly $643 million to enhance its Token Factory AI infrastructure
- A massive $27 billion partnership with Meta elevated the firm’s total contracted pipeline to approximately $50 billion
- Goldman Sachs upgraded its valuation target post-Meta announcement; analyst consensus stands at “Moderate Buy” with $154.75 average projection
- Next quarterly report scheduled for May 13, 2026, with focus on annual recurring revenue and Eigen integration milestones
Shares of Nebius Group (NBIS) kicked off Wednesday’s trading at $175.92, subsequently climbing to a new 52-week pinnacle of $179.96—representing an intraday surge of roughly 9%. Since January, the equity has skyrocketed more than 110%.
This explosive rally follows two transformative announcements released in close succession—the $643 million strategic acquisition of Eigen AI and a groundbreaking $27 billion collaboration with Meta.
The Eigen AI transaction aims to integrate advanced model-optimization and inference technology into Nebius’s Token Factory ecosystem. Industry observers suggest this acquisition could enhance operational margins while positioning the firm to capture a greater share of enterprise-grade AI deployment opportunities.
However, the Meta partnership represents the more substantial catalyst. This singular commitment, combined with pre-existing arrangements including Microsoft and additional clients, has elevated Nebius’s overall contracted pipeline to approximately $50 billion—a figure that invariably captures institutional attention.
Goldman Sachs responded swiftly, elevating its valuation forecast for NBIS following the Meta revelation. Both BWS Financial and DA Davidson maintain $200 price objectives alongside Buy recommendations. Cantor Fitzgerald launched coverage with an Overweight stance, albeit with a more measured $129 projection. Current Street consensus reflects a “Moderate Buy” rating with an aggregate target of $154.75.
Institutional capital has been flowing into the name as well. Millennium Management established a fresh position valued at approximately $11.6 million during Q1. UBS contributed roughly $9 million in new allocations. Oppenheimer expanded its holdings by 90.9% in the fourth quarter. Combined institutional ownership currently represents around 21.9% of outstanding shares.
Understanding the Pipeline Narrative
The $50 billion contracted backlog forms the foundation of the optimistic investment thesis. Extended commitments from hyperscale customers such as Meta and Microsoft provide revenue certainty extending through 2026, when management projects revenue between $3.0 and $3.4 billion.
This degree of forward revenue transparency is uncommon in the sector, explaining why growth-oriented investors have driven shares to unprecedented levels.
Potential Concerns to Monitor
Not every metric presents an optimistic picture. Fiscal 2025 operating cash flow registered approximately $402 million—however, this calculation incorporated nearly $983 million in advance customer payments. Excluding these prepayments reveals a considerably weaker underlying cash generation profile.
Executives have acknowledged that anticipated contracted cash flows will satisfy only approximately 60% of projected 2026 capital investment needs. This funding shortfall presents legitimate concerns regarding potential shareholder dilution or additional debt financing.
Insider disposition activity has also accelerated recently. Chief Technology Officer Danila Shtan divested over 13,000 shares in late March. Insider Andrey Korolenko liquidated more than 31,000 shares in early April. Collectively, company insiders have sold approximately 135,622 shares valued at over $15.6 million throughout the previous three months.
The equity also demonstrates a beta coefficient of 4.03—indicating substantial volatility in either direction. With projected full-year earnings per share of negative $2.44 and a price-to-earnings ratio of -120.49, the current valuation rests entirely on forward expectations.
The Q1 2026 financial release is scheduled for May 13. Market participants will scrutinize annual recurring revenue trends, progress updates regarding hyperscaler implementations, and preliminary indicators concerning the Eigen AI integration roadmap.
